Shares of Enova International cratered as a parade of securities-law firms launched investigations into whether the online lender misled investors about the fate of its $369 million bid for Grasshopper Bancorp. ENVA lost roughly 22.27% of its value overnight when markets opened on September 15, following the company's after-hours disclosure that it had abruptly withdrawn OCC and Federal Reserve applications required to complete the deal. The stock now sits at $134.11, down more than $44 from the week prior, and the legal overhang is compounding the damage.
• Twenty State Attorneys General Helped Kill the Deal — And the Strategy Behind It
Enova cited political pressure and unclear regulatory standards, but the withdrawal followed opposition from 20 state attorneys general concerned about companies using bank partnerships to bypass state interest-rate limits.
Enova had framed the combination as a path to becoming a bank holding company, gaining deposit funding, and expanding products for underserved consumers and small businesses. Without a bank charter, Enova remains dependent on higher-cost wholesale funding — a structural disadvantage that limits margin improvement.
• The Lost Earnings Boost Is Bigger Than the Deal's Price Tag
Management had projected the deal would lift adjusted earnings per share by more than 15% in year one and more than 25% once synergies were realized.
Yet shares fell more than 20%, wiping out equity value well in excess of the deal's headline price — a signal the market had already priced in the bank-charter upside and is now re-pricing the stock as a permanently nonbank lender.
• Law Firms Smell Blood, But the Claims Are Speculative So Far
The investigation centers on whether Enova made materially false or misleading statements regarding the status of and risks to its bank regulatory applications.
At least three firms are probing whether the company "issued false and/or misleading statements and/or failed to disclose information pertinent to investors." No lawsuit has been filed yet. These investigations are common after sharp drops and frequently go nowhere, but they add legal costs and headline risk.
• The Standalone Numbers Still Look Solid — If Investors Care
Enova reaffirmed Q3 guidance of roughly 25% revenue growth and 30% adjusted EPS growth year-over-year, with full-year revenue growth of 20–25% and adjusted EPS growth of 30–35%.
CFO Scott Cornelis pledged to accelerate share buybacks, with $218 million available under debt covenants and $349 million under board authorization. The question now: whether a high-growth nonbank lender with no path to cheap deposits can earn back the valuation it just lost.